Dongguan Kewei's Polypropylene Hernia Mesh Granted CFDA Approval

Shanghai, China - Dongguan Kewei Medical Instrument Co ("Dongguan Kewei"), a wholly-owned subsidiary of Shanghai MicroPort Medical (Group) Co ("MicroPort®"), obtained a registration certificate from China Food and Drug Administration ("CFDA") for its in-house developed Polypropylene Hernia Mesh (product name: THUNDERBIRD®• PURETM) on June 24.
The Polypropylene Hernia Mesh is a sheeted product or three-dimensional combination product made of polypropylene monofilaments by specific weaving technique, mainly used in open tension-free herniorrhaphy or laparo-scopic herniorrhaphy, to replace weakened tissues or fill the defect area. Fixed with certain surgical procedures, the product can bear tension and pressure from the abdomen, and effectively prevent organ prolapse. Its mesh structure provides scaffold for human cells to grow and climb, so as to achieve repair effect. The Polypropylene Hernia Mesh that gains the CFDA approval this time offers six forms and 49 specifications.
The Polypropylene Hernia Mesh is the first of Dongguan Kewei's Hernia Mesh products to be granted CFDA approval. Its market launch will further diversify Dongguan Kewei's product offering and provide more options to surgeons and patients.